Adrenal cortex (mnemonic GFR - ACD)
Renin
Factors stimulating renin secretion
Factors reducing renin secretion
β-blockers
NSAIDS
Angiotensin
Aldosterone
Released by the zona glomerulosa in response to raised angiotensin II, potassium, and ACTH levels
Causes retention of Na+ in exchange for K+/H+ in distal tubule
Anemia in CRF:
Correction o iron with IV if needed
* Ferritin should be > 200 ng/mL before starting EPO
* EPO is used to target Hb 10-12 (>11 or hematocrit >33%) reach the target within 4 months
* Corrected Hb of > 13.5 is associate with HTN crisis
* Hb < 10.5 ↑ risk of seizures.
Erythropoietin:
(EPO) is a hematopoietic growth factor that stimulates the production of erythrocytes. The main uses of erythropoietin are to treat the anemia associated with chronic renal failure and that associated with cytotoxic therapy
Side-effects of erythropoietin
HTN and HTN crisis, potentially → encephalopathy and seizures (BP ↑ in 25% of patients)
* EPO induced seizures occurs after 90 days fro starting the treatment
* Bone aches
* Flu-like symptoms
* Skin rashes, urticaria
* Pure red cell aplasia* (due to antibodies against erythropoietin)
* Raised packed cell volume (PCV) =HCT → ↑ risk of thrombosis (e.g. Fistula)
* Iron deficiency 2nd to ↑ erythropoiesis
There are a number of reasons why patients may fail to respond to erythropoietin therapy
Iron deficiency
* Inadequate dose
* Concurrent infection/inflammation
* Hyperparathyroid bone disease
* Aluminum toxicity
Indication for Urgent Dialysis:
Hyperacute graft rejection is due
pre-existent antibodies to HLA antigens and is therefore IgG
mediated
Graft survival
time frames
1 year = 90%, 10 years = 60% for cadaveric transplants
* 1 year = 95%, 10 years = 70% for living-donor transplants
Renal Transplant: Post-op problems (can cause graft dysfunction) – up to 4 months post-op:
Acute rejection: risk is great in 1st 2 weeks occurs in 30-50% of cases
* Ciclosporin toxicity
* A TN of graft
* V ascular thrombosis
* Urine leakage
* UTI
Hyperacute graft rejection
Causes of chronic graft failure (> 6 months)
Chronic allograft nephropathy
* Ureteric obstruction
* Recurrence of original renal disease (MCGN > IgA > FSGS)
Hyperacute graft rejection is due to pre-existent antibodies to HLA antigens and is therefore IgG
mediated
Autosomal Dominant Polycystic Kidney Disease:
(ADPKD) is the most common inherited cause of kidney disease, affecting 1 in 1,000 Caucasians. Two disease loci have been identified, PKD1 and PKD2, which code for polycystin-1 and polycystin-2 respectively
ADPKD - Ultrasound diagnostic criteria
In < 20 yrs age, CT scan is not needed
* In < 20 yrs age, ultrasound gives false –ve
* 2 cysts, unilateral or bilateral, if aged < 30 years
* 2 cysts in both kidneys if aged 30-59 years
* 4 cysts in both kidneys if aged > 60 years
ADPKD Associtaed conditions:
Colonic diverticula (with any related symptoms, screen by barium enema)
* Mitral Valve Prolapse (needs echo screening)
ADPKD Management:
Autosomal Recessive Polycystic Kidney Disease (ARPKD)
much less common than autosomal dominant disease (ADPKD). It is due to a defect in a gene located on chromosome 6
Diagnosis may be made on prenatal ultrasound or in early infancy with abdominal masses and renal failure. End-stage renal failure develops in childhood. Patients also typically have liver involvement, for example portal and interlobular fibrosis
Nephrotic Syndrome:
Triad of
Nephrotic Syndrome path
Loss of antithrombin-III (↑↑↑), proteins C and S and associated rise in fibrinogen levels
predispose to thrombosis. Loss of TBG lowers total, but not free thyroxin levels
Nephrotic Syndrome Causes